Human Umbilical Cord Blood Infusion in Patients with Cerebral Palsy

A Phase I, Randomized, Double-blind, Placebo-controlled Clinical Study to Assess the Safety and Efficacy of Allogeneic Human Umbilical Cord Blood Infusion in Children with Cerebral Palsy

A phase I, randomized, double-blind, placebo-controlled clinical study to assess the safety and efficacy of allogeneic human umbilical cord blood infusion in children with cerebral palsy

This is a phase I study to evaluate the safety and efficacy in hUCB treatment on the patients with cerebral palsy (CP).

Inclusion Criteria:

• Male or female underage at the time of screening.
• With a confirmed diagnosis of CP
• non-progressive motor disability
• brain dysfunction

Exclusion Criteria:

• Judged by the Investigator to be not suitable/eligible for study participation.